Navigation Links
New Medication May Decrease The Frequency Of Angina Attacks

Nearly 7 million patients suffering from chronic angina report limitations of their work and other activities // two to three times more frequently than the general population. Also, 26 percent of patients still experience angina attacks despite current treatments, such as myocardial revascularization -- a surgery that helps restore blood flow to the heart and is done largely to prevent angina -- and antianginal drugs.

A new treatment may reduce the frequency of angina attacks and help chronic chest pains sufferers exercise longer, according to new research. Researchers say when the drug ranolazine is taken with other antianginal medications, it improves the total exercise time of patients with symptoms of chronic angina.

Ranolazine is currently under review by the FDA. For this study, more than 800 patients with symptomatic chronic angina were randomly assigned to receive a placebo or one or two doses of ranolazine. Patients received either placebos twice a day or 750 mg or 1000 mg of ranolazine. Then, they were monitored as they exercised on a treadmill 12 hours after receiving the medication (when it was at the lowest levels in the bloodstream) and four hours after receiving it (when there were the highest levels of the drug in the bloodstream).

Researchers found that when added to a standard dose of frequently prescribed antianginal drugs, ranolazine can reduce both the angina frequency and nitroglycerin consumption. When compared to the placebo results, the decrease in angina attacks were slightly less than one per week for those in the 750 mg group and somewhat more than one per week in the 1,000 mg group. They also found exercise duration increased by nearly two minutes for those in the ranolazine therapy group compared with 90 seconds for those taking placebos. Specialists say, the availability of another effective and apparently safe antianginal medication is “particularly important” for angina patients who are not candidates
'"/>




Page: 1 2

Related medicine news :

1. What happens when Medications go wrong?
2. Medications to Prevent Relapse to Cocaine Use
3. More Elderly Take Inappropriate and Harmful Medications
4. Medications for depression
5. Medications linked to xerostomia and caries
6. Medication recuperates fat distribution in diabetes
7. Pharmacist’s Role in Medication Error
8. The Downside of Asthma Medication
9. Reducing Medication Errors
10. Oral Medication Effective In Combating Eye Infection
11. Common Medication Errors in Children
Post Your Comments:
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...users of Blackberry email devices on its addictive... the devices could get so addictive that owners mi...ith treatment that is similar to that given to dru...had been carried out by Rutgers University School,...
... fleeting that we could use it in just one tenth o...rch in this area. Researchers say that impressions...vement, because all it needs is just a split secon...decide whether he is worthy of companionship and t...
...st mites in the bedroom can be achieved by replaci...ion, according to a new study.// In “Distribution...urope: The European Community Respiratory Health S...al Institute of Medical Research, Barcelona, Spain...
...ath syndrome has been the cause of many infant dea... sleeps on its back. In a bid to investigate the//..., researchers discovered that infants born with an...were prone to the risk of SIDS. The study has un...
Other Medicine News:Health News:Replacing Old Mattress, Adding Ventilation Reduces Mites 2
(Date:8/18/2008)...fe expectancy for people with,Down syndrome, WASH...world of Down,syndrome, ,Mr. C, is a rarity. A rea...ast 16 years, at seventy, ,Mr. C, has well surpass...wn syndrome, currently in the,late fifties, but in... does,not exhibit clinical symptoms of Alzheimer,s...
(Date:8/18/2008)...n Phase I -, PRINCETON, N.J. and SAN DIEGO, Aug. ...nical stage biotechnology company committed to the...tening and life-altering,infectious diseases, toda...2 by the U.S. Patent and Trademark Office, coverin...in Phase I development for the treatment of HIV-1,...
(Date:8/14/2008)...-- AstraZeneca (NYSE: AZN ),today announced an in...Centre Singapore (NCCS) and the National Universit... The collaboration, which is spelt out in a,Memora... aims to further,build AstraZeneca,s drug developm...ccess to new medicines of potential benefit to pat...
(Date:8/14/2008).../ -- The Clinical Trials,Bootcamp announces its in...nical coordinators, clinical research staff and ot...d in Boca Raton at the Boca Resort from May,14-17t...ators, monitors and,other industry personnel will ...cal trials into a practice, as well as how to take...
Breaking Medicine Technology:Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 2AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 5AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 6Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010 5549 1Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010 5549 2Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010 5549 3Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology 28PCT 29 at Scientific Symposia in Philade 2159 1Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology 28PCT 29 at Scientific Symposia in Philade 2159 2Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology 28PCT 29 at Scientific Symposia in Philade 2159 3Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology 28PCT 29 at Scientific Symposia in Philade 2159 4Studies provide insights into lung disease and lung function in young adults 19977 1Studies provide insights into lung disease and lung function in young adults 19977 2Studies provide insights into lung disease and lung function in young adults 19977 3Crdentia Announces 2008 First Quarter Results 19972 1Crdentia Announces 2008 First Quarter Results 19972 2Crdentia Announces 2008 First Quarter Results 19972 3Crdentia Announces 2008 First Quarter Results 19972 4Crdentia Announces 2008 First Quarter Results 19972 5Crdentia Announces 2008 First Quarter Results 19972 6Crdentia Announces 2008 First Quarter Results 19972 7
... UCB Announces Positive Top-Line Phase III Results... Onset Seizures in,Paediatric Patients from One Mo...gium - April 20, 2007 - UCB today announced,positi...,randomized, multi-centre, placebo-controlled stu...pra® (levetiracetam) (20-50,mg/kg/day) as adju...
...PALO ALTO, Calif.--(BUSINESS WIRE)--Apr 23, 2007 -...ts to date from two separate,Phase 2 clinical tria...ronic kidney disease (CKD) patients. The data show...Hematide could,correct anemia when administered mo...in dialysis patients previously treated with,three...
Other Medicine Technology:UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 2UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 3UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 4UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 5Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month,Hematide for the Treatment of Anemia in Patients with Early- and,End-Stage Chronic Kidney Disease 2Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month,Hematide for the Treatment of Anemia in Patients with Early- and,End-Stage Chronic Kidney Disease 3
Fenestrated 14 mm blades. Wide extension of blade for protection of lids. Self-locking mechanism. Dull finish.
Solid 16 mm blades. Self-locking mechanism. Dull finish.
Infant model. Blades: 7 mm. Solid blades with locking mechanism. Dull finish.
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish.
Medicine Products: